Travere Therapeutics grants inducement equity awards for 41,600 shares to six new employees

Travere Therapeutics, Inc.

Travere Therapeutics, Inc.

TVTX

0.00
  • Travere Therapeutics granted inducement equity awards covering 41,600 shares to six new employees on July 10, 2026.
  • Package includes stock options for 18,000 shares priced at $56.59, with a 10-year term.
  • Options vest over four years: 25% after one year, remainder monthly over the next 36 months.
  • Restricted stock units cover 23,600 shares, vesting 25% on each anniversary over four years.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Travere Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607101700BIZWIRE_USPR_____20260710_BW421515) on July 10, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.